WHY INVEST THROUGH OUR SITE?

The best way to invest in penny stocks is by buying them before they are heavily promoted and hyped up in price. Our free daily penny stock tip sheet can provide you with stocks that will be heavily promoted, or those already in a phase of heavy promotion phase. Heavy promotional campaigns are important to penny stocks. Penny stocks are typically not covered by analyst. As a result, penny stock companies have to rely on heavy promotional campaigns to get the word out about their stock. If you get into the stock at the early phase of that promotional campaign, you could make a fortune.

Once you know which stocks are being heavily promoted, you can buy them ahead of the big PR campaigns and wait to cash in. The difference between the average Joe and the people who make money in penny stocks is that people who make money in penny stocks buy these stocks before they run up in price. The average Joe buys penny stocks after they have run up very high in price. We do all the hard work for you! No experience is required. We find out the stocks that are going to be heavily promoted and alert you to them. You buy the stock at low prices and wait for the price to rise so you can cash out big.

We have compiled a long list of successful stock picks. It is important to add all the stocks we are recommending so that you may create a portfolio of stocks that should provide you with an overall losing percentage.

Featured Stocks Listed Below-----------------------------

Monday, May 19, 2008

Xenacare Holdings Inc. (XCHO.OB)

Company Website
http://www.xenacareholdings.com/

Summary
XenaCare Holdings, Inc. engages in the design, development, marketing, and sale of non-prescription pharmaceuticals (NPPs) and personal lubrication gels. It operates in two divisions, XenaCare Clinical and XenaCare Performance. The XenaCare Clinical division provides XenaCare SOC, a turn-key system for the education, sale, and distribution of NPPs and services at physicians' healthcare offices; and the development, formulation, and brand building of a line of NPPs for the replenishment of nutrients. The XenaCare Performance division involves in the development and formulation of a line of NPPs, such as gels and creams for the personal performance market under the Touch n' Tingle' (TNT) brand; and the development and formulation of a line of NPPs for the energy/lifestyle performance market. XenaCare SOC operates 22 physician offices located in New York and Florida. Its NPPs include XenaCor, XenaTri, and XenaZymePlus, which are distributed through the company's site of care program. The company's TNT gels are used to support the flow and absorption for pleasurable intimacy use without unwanted side effects. It is also developing formulations for the lifestyle performance market, which consists of a sports line for athletes and for the over 50 generation. In addition, it offers body replenishment products to patients treated with prescription drugs for high blood pressure, heart disease, diabetes, ulcers, depression, infection, arthritis, aids, and weight loss. XenaCare Holdings markets its products through the Internet, pharmacies, and doctors' offices. The company was founded in 2001 and is based in Deerfield Beach, Florida.

Recent Activity
SunPill® has been accepted by three major retailers for a summer launch. Starting with Walgreens, the SunPill® will be featured in the sun care aisle of all their 6,500 stores nationwide. Rite-Aide, with a little over 5,000 stores, will feature the SunPill in a special end-cap display that will maintain prominent positioning for the next 14-months; 7-11 will also carry the SunPill® product in a special 6-pack blister display especially designed for the convenience store market in their approximately 7,000 stores nationwide.

The SunPill® is a dietary supplement that helps the skin protect itself from the harmful rays of the sun. It contains scientifically researched ingredients. The SunPill® is a proprietary combination of ingredients with powerful antioxidant properties that help the bodys own natural defense when it comes to exposure to the sun.

Virtually all sun care category managers at major retailers that we have contacted are very enthusiastic about the SunPill® and we believe that it will be the next great product for the summer of 08 and beyond. One major retail buyer who came up through the ranks as a pharmacist stated, The beauty of the SunPill® is that it relies on the fact that it doesnt cannibalize the section. This is a whole new way of addressing over exposure to the sun without taking away our topical sun care sales.

After obtaining the name and concept for SunPill®, XenaCare Holdings re-developed and re-worked the SunPill® to be a major retail item. XenaCare has dedicated much of the past 6-months in the introduction of the SunPill® to the retail world. With a special commitment to consumer education, XenaCare has developed a 60-second direct response TV commercial along with a 30-second commercial that is being tagged with various retailers names.

0 comments: